Irinotecan Hydrochloride Injection — FDA Drug Shortage

No longer listed by FDA — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status No longer listed by FDA. The shortage was first posted on Aug 4, 2025.

Shortage details

Status
No longer listed by FDA
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
45963-614-51
Dosage Form
Injection
Presentation
Irinotecan Hydrochloride, Injection, 20 mg/1 mL (NDC 45963-614-51)
Initial Posting
Aug 4, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.